BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31209787)

  • 1. Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.
    Arab A; Ruda-Kucerova J; Minsterova A; Drazanova E; Szabó N; Starcuk Z; Rektorova I; Khairnar A
    Neurotox Res; 2019 Nov; 36(4):724-735. PubMed ID: 31209787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study.
    Khairnar A; Latta P; Drazanova E; Ruda-Kucerova J; Szabó N; Arab A; Hutter-Paier B; Havas D; Windisch M; Sulcova A; Starcuk Z; Rektorova I
    Neurotox Res; 2015 Nov; 28(4):281-9. PubMed ID: 26153486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and progressive microstructural brain changes in mice overexpressing human α-Synuclein detected by diffusion kurtosis imaging.
    Khairnar A; Ruda-Kucerova J; Szabó N; Drazanova E; Arab A; Hutter-Paier B; Neddens J; Latta P; Starcuk Z; Rektorova I
    Brain Behav Immun; 2017 Mar; 61():197-208. PubMed ID: 27923670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging.
    Khairnar A; Ruda-Kucerova J; Drazanova E; Szabó N; Latta P; Arab A; Hutter-Paier B; Havas D; Windisch M; Sulcova A; Starcuk Z; Király A; Rektorova I
    J Neurochem; 2016 Mar; 136(6):1259-1269. PubMed ID: 26685006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of diffusion kurtosis changes in Parkinson's disease subtypes.
    Sejnoha Minsterova A; Klobusiakova P; Pies A; Galaz Z; Mekyska J; Novakova L; Nemcova Elfmarkova N; Rektorova I
    Parkinsonism Relat Disord; 2020 Dec; 81():96-102. PubMed ID: 33120076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking.
    Kousik SM; Carvey PM; Napier TC
    Eur J Neurosci; 2014 Aug; 40(4):2707-14. PubMed ID: 24890790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microstructure of Brain Nuclei in Early Parkinson's Disease: Longitudinal Diffusion Kurtosis Imaging.
    Welton T; Hartono S; Shih YC; Lee W; Chai PH; Chong SL; Ng SYE; Chia NSY; Choi X; Heng DL; Tan EK; Tan LCS; Chan LL
    J Parkinsons Dis; 2023; 13(2):233-242. PubMed ID: 36744346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion kurtosis imaging detects the time-dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease.
    Khairnar A; Ruda-Kucerova J; Arab A; Hadjistyllis C; Sejnoha Minsterova A; Shang Q; Chovsepian A; Drazanova E; Szabó N; Starcuk Z; Rektorova I; Pan-Montojo F
    J Neurochem; 2021 Aug; 158(3):779-797. PubMed ID: 34107061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
    Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts.
    Imam SZ; el-Yazal J; Newport GD; Itzhak Y; Cadet JL; Slikker W; Ali SF
    Ann N Y Acad Sci; 2001 Jun; 939():366-80. PubMed ID: 11462792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
    Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
    Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging.
    McKenna BS; Brown GG; Archibald S; Scadeng M; Bussell R; Kesby JP; Markou A; Soontornniyomkij V; Achim C; Semenova S;
    Psychiatry Res Neuroimaging; 2016 Mar; 249():27-37. PubMed ID: 27000304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology.
    Praet J; Manyakov NV; Muchene L; Mai Z; Terzopoulos V; de Backer S; Torremans A; Guns PJ; Van De Casteele T; Bottelbergs A; Van Broeck B; Sijbers J; Smeets D; Shkedy Z; Bijnens L; Pemberton DJ; Schmidt ME; Van der Linden A; Verhoye M
    Alzheimers Res Ther; 2018 Jan; 10(1):1. PubMed ID: 29370870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction.
    Virmani A; Gaetani F; Imam S; Binienda Z; Ali S
    Ann N Y Acad Sci; 2002 Jun; 965():225-32. PubMed ID: 12105098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
    Natale G; Kastsiuchenka O; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():345-9. PubMed ID: 18991880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
    Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
    Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study.
    Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
    J Clin Neurosci; 2016 Nov; 33():138-141. PubMed ID: 27499120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A; Wells PG
    Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.